Escalon Medical Corp. (ESMC)
USD 0.16
(-11.11%)
USD 0.16
(-11.11%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -125.26 Thousand USD | -127.42% |
| 2023 | 456.82 Thousand USD | 2426.55% |
| 2022 | 18.08 Thousand USD | 123.67% |
| 2021 | -76.39 Thousand USD | 94.63% |
| 2020 | -1.42 Million USD | -476.03% |
| 2019 | -247.07 Thousand USD | -142.33% |
| 2018 | 583.67 Thousand USD | 180.3% |
| 2017 | -726.89 Thousand USD | 36.87% |
| 2016 | -1.15 Million USD | -112.75% |
| 2015 | -541.24 Thousand USD | -41.73% |
| 2014 | -381.88 Thousand USD | -114.55% |
| 2013 | 2.62 Million USD | 144.15% |
| 2012 | -5.94 Million USD | -3.25% |
| 2011 | -5.75 Million USD | -1291.19% |
| 2010 | -413.86 Thousand USD | 96.81% |
| 2009 | -12.96 Million USD | 13.91% |
| 2008 | -15.05 Million USD | -354.62% |
| 2007 | 5.91 Million USD | 397.82% |
| 2006 | -1.98 Million USD | -181.12% |
| 2005 | 2.44 Million USD | -10.71% |
| 2004 | 2.74 Million USD | 60.11% |
| 2003 | 1.71 Million USD | 74.94% |
| 2002 | 978.85 Thousand USD | 65.29% |
| 2001 | 592.2 Thousand USD | 168.65% |
| 2000 | -862.65 Thousand USD | -171.89% |
| 1999 | 1.2 Million USD | 500.0% |
| 1998 | 200 Thousand USD | 103.51% |
| 1997 | -5.7 Million USD | -39.02% |
| 1996 | -4.1 Million USD | 4.65% |
| 1995 | -4.3 Million USD | 29.51% |
| 1994 | -6.1 Million USD | -12.96% |
| 1993 | -5.4 Million USD | -35.0% |
| 1992 | -4 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -21.19 Thousand USD | -110.69% |
| 2024 Q4 | 134.4 Thousand USD | 182.89% |
| 2024 Q2 | -76.32 Thousand USD | -260.06% |
| 2024 Q3 | -162.14 Thousand USD | -112.46% |
| 2023 Q4 | 198.35 Thousand USD | 102.47% |
| 2023 Q3 | -8.04 Million USD | -66446.16% |
| 2023 Q1 | -325.55 Thousand USD | -750.7% |
| 2023 Q2 | -12.08 Thousand USD | 96.29% |
| 2023 FY | 456.82 Thousand USD | 2426.55% |
| 2022 Q3 | -300.11 Thousand USD | -464.62% |
| 2022 Q1 | 317.22 Thousand USD | 72.85% |
| 2022 Q4 | 50.03 Thousand USD | 116.67% |
| 2022 FY | 18.08 Thousand USD | 123.67% |
| 2022 Q2 | -53.15 Thousand USD | -116.76% |
| 2021 Q3 | -137.46 Thousand USD | -239.59% |
| 2021 Q1 | -196.55 Thousand USD | 58.04% |
| 2021 FY | -76.39 Thousand USD | 94.63% |
| 2021 Q2 | 98.47 Thousand USD | 150.1% |
| 2021 Q4 | 183.51 Thousand USD | 233.5% |
| 2020 Q4 | -468.42 Thousand USD | -266.29% |
| 2020 Q3 | -127.88 Thousand USD | 81.06% |
| 2020 Q2 | -675.34 Thousand USD | -208.69% |
| 2020 FY | -1.42 Million USD | -476.03% |
| 2020 Q1 | 621.37 Thousand USD | 9656.64% |
| 2019 Q4 | -6502.00 USD | -129.28% |
| 2019 Q3 | 22.2 Thousand USD | 110.19% |
| 2019 Q2 | -217.98 Thousand USD | -356.64% |
| 2019 Q1 | -47.73 Thousand USD | -191.71% |
| 2019 FY | -247.07 Thousand USD | -142.33% |
| 2018 Q3 | -119.07 Thousand USD | -116.74% |
| 2018 Q1 | -60.52 Thousand USD | 62.07% |
| 2018 FY | 583.67 Thousand USD | 180.3% |
| 2018 Q4 | 52.05 Thousand USD | 143.71% |
| 2018 Q2 | 711.22 Thousand USD | 1275.16% |
| 2017 Q2 | -64.95 Thousand USD | 83.58% |
| 2017 Q3 | -106.85 Thousand USD | -64.5% |
| 2017 Q4 | -159.55 Thousand USD | -49.31% |
| 2017 FY | -726.89 Thousand USD | 36.87% |
| 2017 Q1 | -395.53 Thousand USD | 22.74% |
| 2016 Q3 | -81.26 Thousand USD | 69.35% |
| 2016 Q2 | -265.1 Thousand USD | 9.58% |
| 2016 Q4 | -511.95 Thousand USD | -529.98% |
| 2016 Q1 | -293.18 Thousand USD | -352.88% |
| 2016 FY | -1.15 Million USD | -112.75% |
| 2015 Q3 | 56.54 Thousand USD | 176.32% |
| 2015 FY | -541.24 Thousand USD | -41.73% |
| 2015 Q1 | -458.95 Thousand USD | -23.16% |
| 2015 Q2 | -74.08 Thousand USD | 83.86% |
| 2015 Q4 | -64.73 Thousand USD | -214.5% |
| 2014 Q2 | -108.54 Thousand USD | -919.79% |
| 2014 Q3 | 86.08 Thousand USD | 179.3% |
| 2014 Q4 | -372.66 Thousand USD | -532.9% |
| 2014 FY | -381.88 Thousand USD | -114.55% |
| 2014 Q1 | 13.24 Thousand USD | 102.04% |
| 2013 Q3 | -285.86 Thousand USD | -107.16% |
| 2013 Q2 | 3.99 Million USD | 1021.33% |
| 2013 Q1 | -433.43 Thousand USD | 55.79% |
| 2013 FY | 2.62 Million USD | 144.15% |
| 2013 Q4 | -649.61 Thousand USD | -127.25% |
| 2012 Q3 | -639.78 Thousand USD | 81.9% |
| 2012 Q4 | -980.36 Thousand USD | -53.23% |
| 2012 FY | -5.94 Million USD | -3.25% |
| 2012 Q1 | -789.64 Thousand USD | 63.07% |
| 2012 Q2 | -3.53 Million USD | -347.67% |
| 2011 Q2 | -1.04 Million USD | -61.53% |
| 2011 FY | -5.75 Million USD | -1291.19% |
| 2011 Q4 | -2.13 Million USD | -11.29% |
| 2011 Q3 | -1.92 Million USD | -83.24% |
| 2011 Q1 | -649.16 Thousand USD | -140.43% |
| 2010 Q1 | -657.49 Thousand USD | 94.08% |
| 2010 Q4 | 1.6 Million USD | 618.99% |
| 2010 FY | -413.86 Thousand USD | 96.81% |
| 2010 Q3 | -309.35 Thousand USD | 70.61% |
| 2010 Q2 | -1.05 Million USD | -60.08% |
| 2009 Q4 | -11.1 Million USD | -1525.36% |
| 2009 FY | -12.96 Million USD | 13.91% |
| 2009 Q3 | -683.17 Thousand USD | 1.98% |
| 2009 Q2 | -696.99 Thousand USD | -44.95% |
| 2009 Q1 | -480.86 Thousand USD | 95.87% |
| 2008 Q2 | -639.34 Thousand USD | 22.86% |
| 2008 Q4 | -11.64 Million USD | -499.65% |
| 2008 Q3 | -1.94 Million USD | -203.85% |
| 2008 FY | -15.05 Million USD | -354.62% |
| 2008 Q1 | -828.79 Thousand USD | 29.32% |
| 2007 Q3 | 8.27 Million USD | 1859.5% |
| 2007 FY | 5.91 Million USD | 397.82% |
| 2007 Q4 | -1.17 Million USD | -114.18% |
| 2007 Q2 | -470.1 Thousand USD | 34.17% |
| 2007 Q1 | -714.11 Thousand USD | 37.48% |
| 2006 Q3 | -576.22 Thousand USD | 41.31% |
| 2006 Q1 | 714.34 Thousand USD | -64.56% |
| 2006 Q2 | -981.8 Thousand USD | -237.44% |
| 2006 Q4 | -1.14 Million USD | -98.23% |
| 2006 FY | -1.98 Million USD | -181.12% |
| 2005 Q4 | 2.01 Million USD | 171.09% |
| 2005 Q3 | 743.55 Thousand USD | 275.94% |
| 2005 Q2 | -422.62 Thousand USD | -464.65% |
| 2005 Q1 | 115.89 Thousand USD | -79.25% |
| 2005 FY | 2.44 Million USD | -10.71% |
| 2004 Q1 | 623.15 Thousand USD | -4.19% |
| 2004 Q4 | 558.43 Thousand USD | -24.45% |
| 2004 Q3 | 739.17 Thousand USD | -9.96% |
| 2004 Q2 | 820.96 Thousand USD | 31.74% |
| 2004 FY | 2.74 Million USD | 60.11% |
| 2003 Q1 | 259.15 Thousand USD | 22.74% |
| 2003 Q3 | 455.13 Thousand USD | 30.91% |
| 2003 FY | 1.71 Million USD | 74.94% |
| 2003 Q4 | 650.41 Thousand USD | 42.91% |
| 2003 Q2 | 347.67 Thousand USD | 34.15% |
| 2002 Q4 | 211.13 Thousand USD | -31.44% |
| 2002 FY | 978.85 Thousand USD | 65.29% |
| 2002 Q3 | 307.97 Thousand USD | 20.57% |
| 2002 Q2 | 255.42 Thousand USD | 236.17% |
| 2002 Q1 | 75.98 Thousand USD | -55.38% |
| 2001 FY | 592.2 Thousand USD | 168.65% |
| 2001 Q2 | 198.91 Thousand USD | 85.22% |
| 2001 Q1 | 107.39 Thousand USD | 127.04% |
| 2001 Q4 | 170.28 Thousand USD | 47.28% |
| 2001 Q3 | 115.61 Thousand USD | -41.87% |
| 2000 Q3 | -633.24 Thousand USD | 47.23% |
| 2000 Q2 | -1.2 Million USD | -185.71% |
| 2000 Q1 | 1.4 Million USD | 1300.0% |
| 2000 FY | -862.65 Thousand USD | -171.89% |
| 2000 Q4 | -397.08 Thousand USD | 37.29% |
| 1999 Q4 | 100 Thousand USD | -87.5% |
| 1999 FY | 1.2 Million USD | 500.0% |
| 1999 Q1 | 200 Thousand USD | 100.0% |
| 1999 Q2 | 100 Thousand USD | -50.0% |
| 1999 Q3 | 800 Thousand USD | 700.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 FY | 200 Thousand USD | 103.51% |
| 1998 Q4 | 100 Thousand USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q1 | - USD | 100.0% |
| 1997 Q3 | -400 Thousand USD | 33.33% |
| 1997 Q4 | -4.3 Million USD | -975.0% |
| 1997 Q1 | -300 Thousand USD | 40.0% |
| 1997 FY | -5.7 Million USD | -39.02% |
| 1997 Q2 | -600 Thousand USD | -100.0% |
| 1996 Q4 | -500 Thousand USD | 75.0% |
| 1996 Q3 | -2 Million USD | -185.71% |
| 1996 Q2 | -700 Thousand USD | 22.22% |
| 1996 Q1 | -900 Thousand USD | 30.77% |
| 1996 FY | -4.1 Million USD | 4.65% |
| 1995 Q2 | -1.1 Million USD | 0.0% |
| 1995 FY | -4.3 Million USD | 29.51% |
| 1995 Q4 | -1.3 Million USD | -62.5% |
| 1995 Q3 | -800 Thousand USD | 27.27% |
| 1995 Q1 | -1.1 Million USD | 35.29% |
| 1994 Q2 | -1.7 Million USD | -30.77% |
| 1994 Q3 | -1.4 Million USD | 17.65% |
| 1994 Q1 | -1.3 Million USD | 0.0% |
| 1994 FY | -6.1 Million USD | -12.96% |
| 1994 Q4 | -1.7 Million USD | -21.43% |
| 1993 Q3 | -1.2 Million USD | 25.0% |
| 1993 FY | -5.4 Million USD | -35.0% |
| 1993 Q2 | -1.6 Million USD | -23.08% |
| 1993 Q4 | -1.3 Million USD | -8.33% |
| 1993 Q1 | -1.3 Million USD | 0.0% |
| 1992 FY | -4 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -722.81 Thousand USD | 82.67% |
| IR-Med Inc. | -4.9 Million USD | 97.448% |
| Polarean Imaging plc | -11.88 Million USD | 98.946% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | 131.724% |
| Avitar, Inc. | -2.25 Million USD | 94.457% |
| AVITA Medical, Inc. | -39.16 Million USD | 99.68% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 89.248% |
| Össur hf. | 58.38 Million USD | 100.215% |
| Zecotek Photonics Inc. | -3.51 Million USD | 96.44% |
| QHSLab, Inc. | -468.36 Thousand USD | 73.256% |
| Wellstar International, Inc. | -3.1 Million USD | 95.97% |
| Össur hf. | 58.38 Million USD | 100.215% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | 105.326% |
| Aurora Spine Corporation | -1.68 Million USD | 92.546% |
| BrainsWay Ltd. | -4.19 Million USD | 97.015% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -11.49 Million USD | 98.91% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | 79.365% |
| Vivos Inc. | -2.89 Million USD | 95.673% |
| MicroPort Scientific Corporation | -477.62 Million USD | 99.974% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | 42.665% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 92.954% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | 70.036% |
| Nanomix Corporation | -12.33 Million USD | 98.984% |
| Theraclion SA | -3.67 Million USD | 96.592% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | 83.365% |
| Positron Corporation | -1.63 Million USD | 92.356% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.64 Million USD | 95.258% |
| Lombard Medical, Inc. | -31.03 Million USD | 99.596% |
| ALR Technologies Inc. | -11.89 Million USD | 98.947% |
| Stratec SE | 14.42 Million USD | 100.868% |
| Vycor Medical, Inc. | -69.69 Thousand USD | -79.738% |
| Heart Tronics, Inc. | -13.32 Million USD | 99.06% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | 0.211% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 99.108% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 99.515% |
| VMS Rehab Systems, Inc. | 46.44 USD | 269826.529% |
| Guided Therapeutics, Inc. | -3.48 Million USD | 96.41% |
| Ingen Technologies, Inc. | -5.06 Million USD | 97.525% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | 86.171% |
| United American Healthcare Corporation | 723 Thousand USD | 117.325% |
| ECGI Holdings, Inc. | -3.61 Million USD | 96.531% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | 80.964% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | 82.526% |
| Urologix, Inc. | -7.6 Million USD | 98.354% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | 92.605% |
| Nexeon MedSystems Inc. | -2.17 Million USD | 94.248% |
| SS Innovations International, Inc. | -20.94 Million USD | 99.402% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | 84.44% |
| Smith & Nephew plc | 263 Million USD | 100.048% |
| NIOX Group Plc | 13.64 Million USD | 100.918% |
| Fuse Medical, Inc. | 1.45 Million USD | 108.58% |
| Broncus Holding Corporation | -28.09 Million USD | 99.554% |
| Brain Scientific Inc. | -12.34 Million USD | 98.985% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 99.573% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | 21.833% |